A comparison of different protease inhibitors on coronary heart disease risk
Coleman, C.I.; White, C.M.
Connecticut Medicine 71(1): 15-17
2007
ISSN/ISBN: 0010-6178 PMID: 17288101 Document Number: 608638
Document emailed within 1 workday
Related Documents
Martens, L.L.; Guibert, R. 1994: Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease Clinical Therapeutics 16(6): 1052-62; discussion 1036McMurray, R.G.; Harrell, J.S.; Griggs, T.R. 1990: A comparison of two fitness programs to reduce the risk of coronary heart disease in public safety officers Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 32(7): 616-620
Aziz, K.; Aziz, S.; Faruqui, A.M.A.; Patel, N.; Chagani, H.; Hafeez, S.A.; Ghuari, S.A.; Memon, M.F.; Ashraf, T.; Sultana, H. 2004: Evaluation and comparison of coronary heart disease risk factor profiles of children in a country with developing economy Jpma. Journal of the Pakistan Medical Association 54(7): 364-371
Rao, N.M.; Pattabiraman, T.N. 1985: Natural plant enzyme inhibitors: comparison of the action of tuber protease inhibitors on animal pancreatic systems Indian Journal of Biochemistry and Biophysics 22(6): 373-375
Barros, Z.M.; de Alencar Ximenes, R.A.; Miranda-Filho, D.óc.B.; de Albuquerque, M.d.F.át.P.M.ão.; Melo, H.ís.R.L.; Carvalho, E.H.; Gelenske, T.; Diniz, G.; Bandeira, F. 2010: Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil Metabolic Syndrome and Related Disorders 8(6): 489-497
Loew, D.; Breddin, K.; Uberla, K. 1982: Inhibitors of thrombocytic function for prophylaxis of coronary heart disease Münchener Medizinische Wochenschrift 124(1): 46-56
Barthélémy, O.; Escaut, L.; Vayre, F.; Gallet, B.; Pulik, M.; Heloire, F.; Vittecoq, D. 2002: Acute coronary syndromes in patients treated with HIV protease inhibitors Presse Medicale 31(8): 343-348
Velican, D.; Petrescu, C.; Velican, C. 1981: The branching anatomical pattern of the coronary arteries as a risk factor for coronary heart disease Medecine Interne 19(2): 173-183
Sattar, N.; Welsh, P.; Sarwar, N.; Danesh, J.; Di Angelantonio, E.; Gudnason, V.; Davey Smith, G.; Ebrahim, S.; Lawlor, D.A. 2010: NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study Atherosclerosis 209(1): 295-299
Ning, X.-h.; Xiang, X.-p.; Lu, N.; Zhang, Y.-x.; Wang, W.-j.; Liu, Y.; Zhou, Z. 2008: Relation of risk factors to coronary artery stenosis severity in coronary atherosclerotic heart disease Zhonghua Yi Xue Za Zhi 88(18): 1267-1269
Agarwal, A.K.; Singla, S.; Singla, S.; Singla, R.; Lal, A.; Wardhan, H.; Yadav, R. 2009: Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease Journal of the Association of Physicians of India 57(1): 135-142
Schmermund, A.; Baumgart, D.; Erbel, R. 2001: Coronary heart disease risk in patients without angina pectoris. Coronary calcinosis as a prognostic factor for myocardial infarct? MMW Fortschritte der Medizin 143(16): 27-29
Ringstad, J.; Jacobsen, B.K.; Thomassen, Y. 1987: The Tromsø Heart Study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease Journal of Trace Elements and Electrolytes in Health and Disease 1(1): 27-31
Hamilton, V.H.; Racicot, F.E.; Zowall, H.; Coupal, L.; Grover, S.A. 1995: The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C JAMA 273(13): 1032-1038
Santiago, L.M.; Serra e Silva, P. 2003: Coronary heart disease risk: the results of population screening by the Central Region Branch of the Portuguese Heart Foundation Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(9): 1039-1048
Guţiu, I.A.; Galeţescu, E.; Guţiu, L.I.; Răducu, L. 1996: Diagonal earlobe crease: a coronary risk factor, a genetic marker of coronary heart disease, or a mere wrinkle. Ancient Greco-Roman evidence Romanian Journal of Internal Medicine 34(3-4): 271-278
Lakka, H.M.; Lakka, T.A.; Tuomilehto, J.; Sivenius, J.; Salonen, J.T. 2000: Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study Archives of Internal Medicine 160(8): 1160-1168
Sang, X.-h.; Yan, S.-f.; Sun, Y. 2012: The prevalence and risk factors of coronary heart disease combined with chronic kidney disease Zhonghua Nei Ke Za Zhi 51(2): 123-126
Zahidullah, M.; Aasim, M.; Khan, I.; Muhammadzai, H.Z.; Shah, M.A.; Ali, N.; Mohammad, A.; Muzahir, A.; Rehman, M. 2012: Evaluation of patients with coronary artery disease for major modifiable risk factors for ischemic heart disease Journal of Ayub Medical College Abbottabad: Jamc 24(2): 102-105
Manfredi, R.; Monari, P.; Donzelli, C.; Furlini, G.; Re, M.C.; Chiodo, F. 1998: Protease inhibitors in antiviral therapy of paediatric HIV disease Acta Paediatrica 87(7): 814-816